Today via China…tips from TFOS member & clinical colleague
Dear friends,
I am Dr. Mingchang Zhang, the director of ophthalmology department of Wuhan Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, and the Chair of the Ophthalmology Society in Hubei Province, China. As you know, in Wuhan, there were over fifty thousand patients infected with coronavirus in the past three months. We had been through a very difficult time, and thanks to the help of our colleagues and our friends all over the country and around the world, the new morbidity number of coronavirus patients has remained to be zero for five consecutive days. Wuhan is getting better, however, the new virus is spreading all over the world and became a pandemic emergency in a lot of countries.
Please be aware that this coronavirus is highly contagious. They could be spread through the respiratory droplet, and contact with the body fluids of patients (Such as tears, saliva, urine). It is also suspected that the virus may also be transmitted through direct contact with the eyes after touching these contaminated surfaces, such as eye touching or rubbing. Sometimes in hospitals where a lot of patients gather,especially in intensive care units, the virus may spread through the air if the concentration of viral aerosols high enough.
According to our latest study, we have detected strong positive expression of the virus in tears of patients with novel coronavirus infection,and in their nasolacrimal ducts that are connected with the respiratory tract. When ophthalmologist examine the patients, it is unavoidable that we are in a very close distance with them, and there are a lot of examination procedures involving direct contact. Therefore, ophthalmology is a department of very high risk under this situation. We must be highly aware of the professional exposure and be fully protected to prevent cross infection. Whenever medical staff are contacting with patients, they must wear masks, gloves and goggles, pay full attention to hand hygiene, wash hands frequently and avoid rubbing their eyes.
From the perspective of patients, it is suggested that ophthalmic patients are excluded from coronavirus infection before consulting. Every patient should wear a mask during examination or treatment. After examination or treatment, any place touched by the patient must be disinfected. At present, there are a few reports of conjunctivitis accompany with other symptoms in patients with coronavirus infection, but the incidence is relatively low. Also there were no serious viral conjunctivitis being identified. Since there is currently no special topical antiviral ophthalmic drug can be used, the major treatment for patients with coronavirus is to alleviate their eye discomforts. The tissues or towel that the patients have used to wipe their eyes or tears, must not be discarded casually and should be disinfected thoroughly.
My dear friends, we understand that the situation in some countries are getting very serious, and we are willing to share our clinical l to help our fellow ophthalmologist and also patients. Together, we believe that we could fight this novel coronavirus. Hope everyone keeps safe and healthy.
Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...
TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide.
By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions.
Together, TFOS and EssilorLuxottica...
TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal.
Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...
Corporate Advisory Board Members
Questo sito utilizza cookie di profilazione propri e di siti terzi. Se vuoi saperne di più consula la cookie policy. Chiudendo questo banner acconsenti all'uso dei cookie. Grazie
